FDA

20 Major Food Recalls Just Since March 2023
Although the number of FDA food recalls only increased marginally from 2021 to 2022 – from 414 to 423 – the total number of food units (for instance, individual containers of baby...
Josie Green
1 month ago

Is Lexicon Pharma a Stock to Buy After 90% Runup and FDA Nod?
Lexicon Pharma shares jumped on Thursday morning after the company announced that it received regulatory feedback from the FDA regarding its heart failure treatment.
Chris Lange
2 years ago

Why This Recently Approved Prostate Cancer Treatment Could Be Huge for Myovant
Myovant shares shot up on Monday after the company announced a new collaboration with Pfizer for its tumor treatment across a couple of indications.
Chris Lange
2 years ago

How Big Is This Setback to Altimmune's COVID-19 Vaccine Candidate?
Altimmune shares dropped on Thursday after the company announced that it had received an update from the FDA regarding its COVID-19 vaccine candidate.
Chris Lange
2 years ago
Last Updated: 2 years ago

Why Gilead Retreated on Rheumatoid Arthritis Treatment
Galapagos was crushed on Wednesday after the firm, in conjunction with Gilead, announced a new commercialization and development agreement for their Rheumatoid Arthritis (RA) treatment.
Chris Lange
2 years ago

Why One Analyst Sees Big Upside in This COVID-19 Vaccine Stock
BioNTech was in the spotlight on Tuesday after it received a sizable price target hike from one key analyst.
Chris Lange
2 years ago

Is the FDA's CRL on scPharma Justified?
After scPhamaceuticals announced that it had received a Complete Response Letter from the FDA, its shares were absolutely crushed on Monday.
Chris Lange
2 years ago

Vanda Investors Can Sleep Easy With This FDA Approval
Vanda Pharma shares jumped on Wednesday after the company announced an update from the FDA regarding its treatment for nighttime sleep disturbances associated with Smith-Magenis syndrome.
Chris Lange
2 years ago

Moderna's COVID-19 Vaccine Is on the Way: Here's What You Need to Know
Moderna shares continued to run higher on Monday after the company announced an update for the primary efficacy analysis for its late-stage coronavirus vaccine trial.
Chris Lange
2 years ago

Mixed Views So Far on FDA Approval of Biogen's Aducanumab for Alzheimer's
24/7 Wall St. has tracked multiple analyst calls regarding the expected approval or nonapproval of aducanumab as the first viable treatment against Alzheimer's disease.
Jon C. Ogg
2 years ago

Is Biogen Setting Up for a Big Alzheimer's Win?
Biogen shares rocketed up on Wednesday after briefing documents from the FDA provided evidence of the effectiveness of the firm’s Alzheimer’s disease treatment.
Chris Lange
2 years ago
Last Updated: 2 years ago

Is This Peanut Allergy Treatment Back on the Table?
DBV Technologies is making a comeback after making headway for its peanut allergy treatment in Europe.
Chris Lange
2 years ago

Did Regeneron Just Revive Hopes About Beating COVID-19?
The novel coronavirus has wiped out trillions of dollars in global output with more than 1 million deaths worldwide in 2020. With cases rising rapidly in the United States and in Europe, more...
Jon C. Ogg
2 years ago

Gilead Is the First COVID-19 Stock to Win FDA Approval
Gilead Sciences is the first company to cross the finish line for regulatory approval in the fight against the coronavirus.
Chris Lange
2 years ago

A Look at the FDA's Most Recent COVID-19 Approval
OraSure Technologies shares jumped to start off the week after the company announced an update from the FDA in regards to its COVID-19 test kit.
Chris Lange
2 years ago